MARÍA CRISTINA
SÁNCHEZ GARCÍA
Profesora titular de universidad
Publicaciones (60) Publicaciones de MARÍA CRISTINA SÁNCHEZ GARCÍA
2024
-
Fatty acid amide hydrolase drives adult mammary gland development by promoting luminal cell differentiation
Cell Death Discovery, Vol. 10, Núm. 1
2023
-
Exploring the 1,3-benzoxazine chemotype for cannabinoid receptor 2 as a promising anti-cancer therapeutic
European Journal of Medicinal Chemistry, Vol. 259
-
Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer
Nature Communications, Vol. 14, Núm. 1
-
Neuronal Cannabinoid CB1 Receptors Suppress the Growth of Melanoma Brain Metastases by Inhibiting Glutamatergic Signalling
Cancers, Vol. 15, Núm. 9
-
miR-203 drives breast cancer cell differentiation
Breast Cancer Research, Vol. 25, Núm. 1
2022
-
An optimized MNK1b aptamer, apMNKQ2, and its potential use as a therapeutic agent in breast cancer
Molecular Therapy - Nucleic Acids, Vol. 30, pp. 553-568
-
Glycosylation of Epigallocatechin Gallate by Engineered Glycoside Hydrolases from Talaromyces amestolkiae: Potential Antiproliferative and Neuroprotective Effect of These Molecules
Antioxidants, Vol. 11, Núm. 7
2019
-
Therapeutic targeting of HER2–CB 2 R heteromers in HER2-positive breast cancer
Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, Núm. 9, pp. 3863-3872
-
2.- Preparaciones de cannabis medicinal
Usos medicinales del cannabis: ¿qué sabemos de sus propiedades curativas? (Los Libros de la Catarata), pp. 33-44
-
Erratum: Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer (Proceedings of the National Academy of Sciences of the United States of America (2019) 116 (3863–3872) DOI: 10.1073/pnas.1815034116)
Proceedings of the National Academy of Sciences of the United States of America
-
Transglycosylation products generated by Talaromyces amestolkiae GH3 β-glucosidases: Effect of hydroxytyrosol, vanillin and its glucosides on breast cancer cells
Microbial Cell Factories, Vol. 18, Núm. 1
2018
-
Appraising the “entourage effect”: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer
Biochemical Pharmacology, Vol. 157, pp. 285-293
2017
-
In situ localization of tumor cells associated with the epithelial-mesenchymal transition marker Snail and the prognostic impact of lymphocytes in the tumor microenvironment in invasive ductal breast cancer
Experimental and Molecular Pathology, Vol. 102, Núm. 2, pp. 268-275
-
Loss of Cannabinoid CB1 Receptors Induces Cortical Migration Malformations and Increases Seizure Susceptibility
Cerebral Cortex, Vol. 27, Núm. 11, pp. 5303-5317
2016
-
Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer
Oncotarget, Vol. 7, Núm. 30, pp. 47565-47575
-
Anticancer mechanisms of cannabinoids
Current Oncology, Vol. 23, pp. S23-S32
2015
-
Efficient in vivo antitumor effect of an immunotoxin based on ribotoxin α-sarcin in nude mice bearing human colorectal cancer xenografts
SpringerPlus, Vol. 4, Núm. 1
-
Endocannabinoids and cancer
Handbook of Experimental Pharmacology (Springer New York LLC), pp. 449-472
-
Loss of Tribbles pseudokinase-3 promotes Akt-driven tumorigenesis via FOXO inactivation
Cell Death and Differentiation, Vol. 22, Núm. 1, pp. 131-144
-
New inhibitors of angiogenesis with antitumor activity in vivo
Journal of Medicinal Chemistry, Vol. 58, Núm. 9, pp. 3757-3766